Enter your terms above and click the 'Search' button.

Showing articles 0 to 6 of 6 Filter Applied: multiple sclerosis (Click to remove) Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis NEJM 376:221-234,280, Hauser, S.L.,et al, 2017 Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis NEJM 376:209-220,280, Montalban, X.,et al, 2017 B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis NEJM 358:676-688, Hauser,S.L.,et al, 2008 Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008 Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008 Lymphocyte Adherence in Multiple Sclerosis Neurol 29:232-235, Dore-Duffy,P.,et al, 1979 Showing articles 0 to 6 of 6